Al Wajer Pharmaceuticals is the only Pharmaceuticals Pellets manufacturer in the MENA region. Promoted by a dynamic team of techno-commercial professionals with decades of experience in the pharmaceutical world. Our promoter’s moto is deeply rooted in the belief of maintaining business ethics and to meet customer satisfaction.
The factory is located over a land area of 15,000 sqm. in the industrial land of Sohar in the Sultanate. Al Wajer manufactures a wide range of drug-loaded pharma pellets. The production facility complies with the WHO GMP standards and ISO 9001 Quality Management System Standards. Al Wajer started its operations from 2012 and since then have been serving the pharmaceutical industry across the globe. The plant currently has an installed capacity of 20 MT. The facility consists of the production unit, complete laboratory facilities along with R&D facility. It is a 100% export-oriented unit and exports its products to countries in the Middle East, Latin America, Africa and Asia.
We know that the only way to achieve excellence in our company is to align our human resources with this objective. That is why we strive to surround ourselves with reliable people, of youthful spirit and honest heart, enterprising and perseverant. We wish to be recognized worldwide by our quality, flexibility and friendly service.
Mission
- Leading manufacturer of Pharmaceutical Pellets in the Middle East Region.
- Contributing towards superior healthcare through research & development.
- Maximizing value for our stakeholders.
Vision
Manufacturing and supplying pharmaceutical pellets at an affordable cost by optimizing the cost of production & continuous process and product improvement.
Our strength
- State of art facility.
- Complete automation in transfer of products.
- Identification, development and introduction of niche molecules.
- Al Wajer team consists of professionals ranging from Doctorate to MSc.
- Management with more than 35 years industry experience.
- Marketing team with more than 25 years industry experience.
Global presence
